Optimi Health (CNSX:OPTI) has established itself as a GMP-certified manufacturer of psychedelic drug products, supplying psilocybin and MDMA for clinical research and regulated access programs. The ...
Some anecdotal and early research evidence suggests that ibogaine, a compound derived from a shrub in western Central African, may help reduce symptoms of drug and alcohol withdrawal, ease cravings, ...
Ibogaine—a psychoactive plant derivative—has attracted attention for its anti-addictive and anti-depressant properties. But ibogaine is a finite resource, extracted from plants native to Africa like ...
A recent executive order directing federal agencies to accelerate research pathways for psychedelic drugs named only one compound specifically by name: ibogaine. The announcement was framed as the ...
Ibogaine is a naturally occurring alkaloid extracted from the root bark of Tabernanthe iboga, a plant native to Central Africa. Traditionally used in spiritual healing ceremonies, it has recently ...
In June 2025, Gov. Greg Abbott signed legislation creating a $50 million grant program to put Texas at the forefront of ibogaine research. Ibogaine is one of several illicit drugs, such as LSD and ...
Ibogaine is a psychoactive alkaloid found in the root bark of Tabernanthe iboga, a shrub native to Central and West Africa. For generations it has been used in Bwiti spiritual and initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results